InMed Pharmaceuticals Inc. Common Shares
INM •
Sell Open
Signal type
Sell
Status
Open
Open Price
$2.02
Stop Loss
$3.55
Performance
64.62%
Days Open
175
Signal Setup
Signal Type Sell
Status Open
Open Date Oct 22, 2025
Open Price $2.02
Stop Loss $3.55
Timespan Day
Company Profile
Name InMed Pharmaceuticals Inc. Common Shares
Ticker INM
Market Cap $9.76M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $0.71
List Date Nov 10, 2020
Description
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Website Open Company Website